Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 3 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Position Overview
Tessera is seeking an experienced physician with expertise in hematology to serve as the Medical Monitor for our innovative Gene Writing™ clinical programs. This individual will provide medical oversight across clinical studies, ensuring patient safety, protocol compliance, data integrity, and high-quality study execution while partnering closely with Clinical Operations, Safety, Regulatory, Biometrics, and Translational teams.
Reporting to the Chief Medical & Development Officer, the Medical Monitor will play a critical role in the design, conduct, and interpretation of early-stage clinical trials for novel genomic medicines targeting hematologic diseases, with indications that may include sickle cell disease and hematologic malignancies. The successful candidate will serve as the primary medical resource for investigators, CRO partners, and internal study teams while helping shape clinical development strategy through a deep understanding of hematologic disorders and emerging therapeutic approaches.
The position is based at Tessera’s headquarters in Somerville, MA, with a flexible hybrid work environment. Approximately 10–20% travel may be required.
Key Responsibilities
Medical Monitoring & Clinical Oversight
• Serve as the primary Medical Monitor for clinical studies, providing ongoing medical oversight throughout study conduct.
• Review eligibility criteria, protocol deviations, safety events, laboratory data, and emerging clinical findings to ensure patient safety and protocol compliance.
• Participate in investigator meetings, study start-up activities, site training, and ongoing investigator engagement.
• Collaborate with Clinical Operations and CRO partners to support efficient trial execution, enrollment, and study milestones.
• Provide timely medical review and adjudication of adverse events, serious adverse events, and other safety signals.
Safety Leadership
• Conduct regular review of accumulating safety data and contribute to benefit-risk assessments.
• Partner with Pharmacovigilance and Safety teams to identify, evaluate, and manage emerging safety concerns.
• Contribute to safety monitoring plans, Data Monitoring Committee materials, and regulatory safety reporting activities.
• Ensure studies are conducted in accordance with ICH-GCP, FDA, EMA, and other applicable regulatory requirements.
Clinical Development Contributions
• Provide medical input into clinical protocols, investigator brochures, informed consent forms, clinical study reports, and regulatory submissions.
• Support interpretation of clinical efficacy, pharmacodynamic, biomarker, and safety data.
• Collaborate with cross-functional teams to evaluate clinical findings and inform future development decisions.
• Contribute to study design discussions and clinical development strategy for hematology programs.
Scientific & External Engagement
• Develop and maintain expertise in hematologic diseases, emerging therapies, and competitive developments.
• Establish productive relationships with investigators, key opinion leaders, patient advocacy organizations, and academic collaborators.
• Represent Tessera at scientific meetings, advisory boards, and external forums.
• Support publication, abstract, and presentation development.
Cross-Functional Leadership
• Partner closely with Clinical Operations, Regulatory Affairs, Biometrics, Translational Medicine, Clinical Pharmacology, and Safety teams.
• Identify and proactively address operational, medical, and scientific risks.
• Foster a culture of scientific rigor, collaboration, patient focus, and operational excellence.
Qualifications
Required
• MD, MD/PhD, or equivalent medical degree with board certification in Hematology, dual certification in Hematology/Oncol
Apply on employer site ↗